Statin pretreatment in experimental acute pancreatitis

Journal of the Pancreas

Volumn 9, Issue 4, 2008, Pages 431-439

  Almeida, José Luiz ^a,b   Sampietre, Sandra Nassa ^a   Mendonça Coelho, Ana Maria ^a   Trindade Molan, Nilza Aparecida ^a   Machado, Marcel Cerqueira César ^a   Monteiro da Cunha, José Eduardo ^a   Jukemura, José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Hydroxymethylglutaryl CoA reductase inhibitors; Inflammation; Pancreatitis

Indexed keywords

AMYLASE; CERULETIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE; SIMVASTATIN; SODIUM CHLORIDE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; MALE; MORTALITY; NONHUMAN; RAT; SURVIVAL; WATER CONTENT; WISTAR RAT;

ACUTE DISEASE; ANIMALS; CAERULEIN; DISEASE MODELS, ANIMAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-10; INTERLEUKIN-6; LUNG; MALE; PANCREATITIS; PEROXIDASE; RATS; SIMVASTATIN; SURVIVAL RATE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48949099320     PISSN: None     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5:132-44.
2. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 1999, 25:195-210.
3. Montagnini AL, Kubrusly MS, Coelho AM, Molan NA, da Cunha JE, Machado MC, Pinotti HW. Effect of omeprazole administration on pancreatic content of enzymes in rats. Rev Hosp Clin Fac Med Sao Paulo 1995; 50:272-5.
4. Salem MZ, Cunha JE, Coelho AM, Sampietri SN, Machado MC, Penteado S, Abdo EE. Effects of octreotide pretreatment in experimental acute pancreatitis. Pancreatology 2003, 3:164-8.
5. de Souza LJ, Sampietre SN, Assis RS, Knowles CH, Leite KF, Jancar S, et al. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg 2001; 5:364-70.
6. Abdo EE, Machado MC, Coelho AM, Sampietre SN, Leite KR, Molan NA, Pinotti HW. Antioxidative effect of N2-mercaptopropionylglycine (N2 MPG) in experimental acute pancreatitis. Rev Hosp Clin Fac Med Sao Paulo 1998; 53:169-73.
7. Mota R, Sánchez-Bueno F, Berenguer-Pina JJ, Hernández-Espinosa D, Parrilla P, Yélamos J. Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury. Br J Pharmacol 2007; 151:998-1005.
8. Tang WF, Wang YG, Zhu L, Wan MH, Chen GY, Xia Q, et al. Effect of somatostatin on immune inflammatory response in patients with severe acute pancreatitis. J Dig Dis 2007; 8:96-102.
9. Seo SW, Jung WS, Piao TG, Hong SH, Yun KJ, Park RK, et al. Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats. World J Gastroenterol 2007; 13:2298-304.
10. Xu P, Zhou XJ, Chen LQ, Chen J, Xie Y, Lv LH, Hou XH. Pioglitazone attenuates the severity of sodium taurocholate-induced severe acute pancreatitis. World J Gastroenterol 2007; 13:1983-8.
11. Isik AT, Mas MR, Yamanel L, Aydin S, Comert B, Akay C, et al. The role of allopurinol in experimental acute necrotizing pancreatitis. Indian J Med Res 2006, 124:709-14.
12. Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. TNF-alpha as a therapeutic target in acute pancreatitis-lessons from experimental models. ScientificWorldJournal 2007; 7:431-48.
13. Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, et al. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 2007, 27:542-51.
14. Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Kishi S, Sawa H, et al. Protective effect of caspase inhibitor on intestinal integrity in experimental severe acute pancreatitis. J Surg Res 2007, 138:300-7.
15. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110:880-5.
16. Diomede L, Albani D, Sottocorno M, Donati MB, Bianchi M, Fruscella P, Salmona M. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 2001; 21:1327-32.
17. Almog Y. Statins, inflammation, and sepsis: hypothesis. Chest 2003; 124:740-3.
18. Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int 2003, 63:12-23.
19. Choi OS, Park SJ, Seo SW, Park CS, Cho JJ, Ahn HJ. The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, lovastatin (statin) ameliorates CCK-induced acute pancreatitis in rats. Biol Pharm Bull 2005; 28:1394-97.
20. Kwak BR, Mach F. Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol 2001; 21:1256-8.
21. Jaster R, Brock P, Sparmann G, Emmrich J, Liebe S. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003; 65:1295-303.
22. Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, Weber C. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004; 109:2560-5.
23. Wierzbicki AS, Poston R, Ferro A. The lipid and non-lipid effects of statins. Pharmacol Ther 2003; 99:95-112.
24. Abdo EE, Coelho AM, Montagnini AL, Kubrusly MS, Leite KR, Sampietre SN, et al. Simplified model of induction of experimental acute pancreatitis with a supra-maximal dose of cerulein. Rev Hosp Clin Fac Med Sao Paulo 1994; 49:204-7.
25. Lankisch PG, Ihse I. Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987; 22:257-60.
26. Bernfeld P. Amylase. Methods Enzymol 1955, 1: 149-50.
27. Jamieson AD, Pruitt KM, Caldwell RC. An improved amylase assay. J Dent Res 1969; 48:483.
28. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 1985; 59:1978-85.
29. Warren JS, Yabroff KR, Mandel DM, Johnson KJ, Ward PA. Role of O2- in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radic Biol Med 1990; 8:163-72.
30. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215:44-56.
31. Institute of Laboratory Animals Resources. Guide for the Care and Use of Laboratory Animals. Washington, DC, USA: National Academy Press, 1996.
32. de Almeida JL, Jukemura J, Coelho AM, Patzina RA, Machado MC, da Cunha JE. Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics 2006; 61:301-6.
33. Machado MC, Coelho AM, Pontieri V, Sampietre SN, Molan NA, Soriano F, et al. Local and systemic effects of hypertonic solution (NaCl 7.5%) in experimental acute pancreatitis. Pancreas 2006; 32:80-6.
34. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(21 Suppl 1):II2-10.
35. Liappis AP, Kan VL, Rochester CG, Simon GL. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 2001; 33:1352-57.
36. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7-22.
37. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344:1383-89.
38. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
39. Berney T, Gasche Y, Robert J, Jenny A, Mensi N, Grau G, et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999; 4:371-7.
40. Yamauchi J, Shibuya K, Sunamura M, Arai K, Shimamura H, Motoi F, et al. Cytokine modulation in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001; 8:195-203.
41. Wereszczynska-Siemiatkowska U, Dabrowski A, Siemiatkowski A, Mroczko B, Laszewicz W, Gabryelewicz A. Serum profiles of E-selectin, interleukin-10, and interleukin-6 and oxidative stress parameters in patients with acute pancreatitis and nonpancreatic acute abdominal pain. Pancreas 2003; 26:144-52.
42. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Devière J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108:1917-22.
43. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112:960-7.
44. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9:401-10.
45. Dumot JA, Conwell DL, Zuccaro G Jr, Vargo JJ, Shay SS, Easley KA, Ponsky JL. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001; 96:2098-102.
46. Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997; 42:1469-72.
47. Han XC, Zhang YC, Wang Y, Jia MK. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2003; 2:135-8.
48. Zou WG, Wang DS, Lang MF, Jin DY, Xu DH, Zheng ZC, et al. Human interleukin 10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats. J Surg Res 2002; 103:121-6.
49. Van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Devière J. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998; 43:408-13.
50. Stimac D, Fisić E, Milić S, Bilić-Zulle L, Perić R. Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J Clin Gastroenterol 2006; 40:209-12.
51. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47:546-52.
52. McKay CJ, Gallagher G, Brooks B, Imarie CW, Baxter JN. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996; 83:919-23.